Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Daniel Wachtlin |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression -- The EMC trial / André Tadic en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No. 4 (Abril)
[artículo]
Título : Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression -- The EMC trial Tipo de documento: texto impreso Autores: André Tadic, Autor ; Daniel Wachtlin, Autor ; Matthias Berger, Autor Fecha de publicación: 2021 Artículo en la página: pp. 705-716 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Antidepresivos, Farmacoterapia, RCT, Mejora temprana, Pautas Resumen: Patients with Major Depressive Disorder (MDD) and no improvement after two weeks of antidepressant pharmacotherapy have a high risk of treatment failure. The aim of the study was to determine whether an early medication change (EMC) strategy is superior to a guideline-based treatment in MDD patients without improvement after two weeks of antidepressant pharmacotherapy. Link: ./index.php?lvl=notice_display&id=26570
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 4 (Abril) . - pp. 705-716[artículo] Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression -- The EMC trial [texto impreso] / André Tadic, Autor ; Daniel Wachtlin, Autor ; Matthias Berger, Autor . - 2021 . - pp. 705-716.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 4 (Abril) . - pp. 705-716
Palabras clave: Trastorno depresivo mayor, Antidepresivos, Farmacoterapia, RCT, Mejora temprana, Pautas Resumen: Patients with Major Depressive Disorder (MDD) and no improvement after two weeks of antidepressant pharmacotherapy have a high risk of treatment failure. The aim of the study was to determine whether an early medication change (EMC) strategy is superior to a guideline-based treatment in MDD patients without improvement after two weeks of antidepressant pharmacotherapy. Link: ./index.php?lvl=notice_display&id=26570